Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Hims & Hers launched a $49 Wegovy-like drug, triggering Novo Nordisk’s legal threat over IP and sparking safety concerns.

flag Hims & Hers has launched a $49 version of the weight-loss drug Wegovy, prompting Novo Nordisk to threaten legal action over intellectual property rights. flag The company's version is a compounded formulation, not an approved generic, raising concerns about safety and regulatory compliance. flag The move has disrupted the market, causing Novo Nordisk's stock to drop.

58 Articles